940 Shares in Oracle Corporation $ORCL Purchased by Weil Company Inc.

Weil Company Inc. purchased a new stake in Oracle Corporation (NYSE:ORCL) during the 2nd quarter, HoldingsChannel reports. The fund purchased 940 shares of the enterprise software provider’s stock, valued at approximately $205,000.

A number of other large investors have also recently modified their holdings of ORCL. Snider Financial Group grew its stake in Oracle by 1.3% in the 2nd quarter. Snider Financial Group now owns 3,204 shares of the enterprise software provider’s stock worth $701,000 after buying an additional 40 shares in the last quarter. SNS Financial Group LLC grew its position in Oracle by 0.9% in the second quarter. SNS Financial Group LLC now owns 4,896 shares of the enterprise software provider’s stock worth $1,070,000 after acquiring an additional 42 shares in the last quarter. Reyes Financial Architecture Inc. increased its stake in Oracle by 7.2% in the second quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock valued at $141,000 after acquiring an additional 43 shares during the last quarter. Creative Capital Management Investments LLC increased its stake in Oracle by 5.7% in the second quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock valued at $174,000 after acquiring an additional 43 shares during the last quarter. Finally, MFA Wealth Services raised its position in Oracle by 1.0% during the second quarter. MFA Wealth Services now owns 4,563 shares of the enterprise software provider’s stock valued at $998,000 after purchasing an additional 43 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Insider Activity

In other Oracle news, CEO Clayton M. Magouyrk sold 40,000 shares of the company’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total value of $11,065,600.00. Following the completion of the transaction, the chief executive officer directly owned 154,030 shares in the company, valued at approximately $42,610,859.20. This represents a 20.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the sale, the director directly owned 17,764 shares in the company, valued at $5,435,784. The trade was a 39.30% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 204,254 shares of company stock valued at $60,227,807. 40.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ORCL. UBS Group raised their price objective on Oracle from $360.00 to $380.00 and gave the company a “buy” rating in a report on Friday, October 17th. Scotiabank boosted their price objective on shares of Oracle from $350.00 to $360.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. JPMorgan Chase & Co. upped their price objective on shares of Oracle from $185.00 to $210.00 and gave the company a “neutral” rating in a research note on Monday, September 8th. BNP Paribas set a $377.00 target price on shares of Oracle in a research report on Wednesday, September 10th. Finally, BMO Capital Markets set a $355.00 price target on shares of Oracle and gave the stock an “outperform” rating in a research note on Monday, October 13th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Oracle has a consensus rating of “Moderate Buy” and a consensus price target of $323.69.

Oracle Price Performance

Shares of Oracle stock opened at $241.02 on Tuesday. The company’s fifty day simple moving average is $279.62 and its two-hundred day simple moving average is $232.02. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The firm has a market cap of $687.10 billion, a PE ratio of 55.79, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business’s revenue was up 12.2% on a year-over-year basis. During the same period last year, the company posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities analysts expect that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.